OBSEVA SA (OBSV) Stock Fundamental Analysis

NASDAQ:OBSV • CH0346177709

0.1018 USD
-0.02 (-15.52%)
At close: Mar 22, 2023
0.0826 USD
-0.02 (-18.86%)
After Hours: 3/22/2023, 8:20:53 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

OBSV gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 521 industry peers in the Biotechnology industry. Both the profitability and financial health of OBSV have multiple concerns. OBSV is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • OBSV had negative earnings in the past year.
  • OBSV had a negative operating cash flow in the past year.
OBSV Yearly Net Income VS EBIT VS OCF VS FCFOBSV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -20M -40M -60M -80M -100M

1.2 Ratios

  • The profitability ratios for OBSV are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OBSV Yearly ROA, ROE, ROICOBSV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 -200 -400 -600 -800

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for OBSV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OBSV Yearly Profit, Operating, Gross MarginsOBSV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 -100K -200K -300K -400K -500K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • OBSV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OBSV has been increased compared to 1 year ago.
  • OBSV has a better debt/assets ratio than last year.
OBSV Yearly Shares OutstandingOBSV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M
OBSV Yearly Total Debt VS Total AssetsOBSV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -45.57, we must say that OBSV is in the distress zone and has some risk of bankruptcy.
  • OBSV's Altman-Z score of -45.57 is on the low side compared to the rest of the industry. OBSV is outperformed by 91.76% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -45.57
ROIC/WACCN/A
WACC8.72%
OBSV Yearly LT Debt VS Equity VS FCFOBSV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 50M -50M 100M

2.3 Liquidity

  • A Current Ratio of 0.61 indicates that OBSV may have some problems paying its short term obligations.
  • OBSV has a worse Current ratio (0.61) than 91.76% of its industry peers.
  • A Quick Ratio of 0.61 indicates that OBSV may have some problems paying its short term obligations.
  • OBSV has a worse Quick ratio (0.61) than 91.28% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.61
OBSV Yearly Current Assets VS Current LiabilitesOBSV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.94% over the past year.
  • The Revenue for OBSV has decreased by -57.43% in the past year. This is quite bad
  • OBSV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 298.56% yearly.
EPS 1Y (TTM)6.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-110%
Revenue 1Y (TTM)-57.43%
Revenue growth 3Y901.88%
Revenue growth 5Y298.56%
Sales Q2Q%-81.53%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.26% on average over the next years. This is a very strong growth
  • OBSV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.07% yearly.
EPS Next Y12.85%
EPS Next 2Y32.71%
EPS Next 3Y26.26%
EPS Next 5YN/A
Revenue Next Year-33.03%
Revenue Next 2Y-41.42%
Revenue Next 3Y14.26%
Revenue Next 5Y11.07%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
OBSV Yearly Revenue VS EstimatesOBSV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2026 2027 10M 20M 30M 40M
OBSV Yearly EPS VS EstimatesOBSV Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • OBSV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year OBSV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OBSV Price Earnings VS Forward Price EarningsOBSV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OBSV Per share dataOBSV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • OBSV's earnings are expected to grow with 26.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.71%
EPS Next 3Y26.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OBSV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

OBSEVA SA

NASDAQ:OBSV (3/22/2023, 8:20:53 PM)

After market: 0.0826 -0.02 (-18.86%)

0.1018

-0.02 (-15.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-09
Earnings (Next)08-15
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.95%
Ins Owner Change0%
Market Cap8.60M
Revenue(TTM)8.57M
Net Income(TTM)-76.70M
Analysts45.71
Price Target12.24 (11923.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.4%
Min EPS beat(2)-121.65%
Max EPS beat(2)98.85%
EPS beat(4)2
Avg EPS beat(4)-2.12%
Min EPS beat(4)-121.65%
Max EPS beat(4)98.85%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)51188.3%
Min Revenue beat(2)45.28%
Max Revenue beat(2)102331%
Revenue beat(4)3
Avg Revenue beat(4)25589.6%
Min Revenue beat(4)-40.77%
Max Revenue beat(4)102331%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)84.62%
PT rev (3m)157.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS0.1
BVpS-0.04
TBVpS-0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.29%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.61
Altman-Z -45.57
F-Score3
WACC8.72%
ROIC/WACCN/A
Cap/Depr(3y)228.57%
Cap/Depr(5y)1654.55%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-110%
EPS Next Y12.85%
EPS Next 2Y32.71%
EPS Next 3Y26.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-57.43%
Revenue growth 3Y901.88%
Revenue growth 5Y298.56%
Sales Q2Q%-81.53%
Revenue Next Year-33.03%
Revenue Next 2Y-41.42%
Revenue Next 3Y14.26%
Revenue Next 5Y11.07%
EBIT growth 1Y23.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.03%
OCF growth 3YN/A
OCF growth 5YN/A

OBSEVA SA / OBSV FAQ

Can you provide the ChartMill fundamental rating for OBSEVA SA?

ChartMill assigns a fundamental rating of 2 / 10 to OBSV.


Can you provide the valuation status for OBSEVA SA?

ChartMill assigns a valuation rating of 0 / 10 to OBSEVA SA (OBSV). This can be considered as Overvalued.


What is the profitability of OBSV stock?

OBSEVA SA (OBSV) has a profitability rating of 1 / 10.


How financially healthy is OBSEVA SA?

The financial health rating of OBSEVA SA (OBSV) is 0 / 10.


Can you provide the expected EPS growth for OBSV stock?

The Earnings per Share (EPS) of OBSEVA SA (OBSV) is expected to grow by 12.85% in the next year.